OraSure (OSUR) Investors Can Put Terminated AbbVie (ABBV) Agreement in Rear View as Other Opportunities About - BTIG
Tweet Send to a Friend
BTIG affirms OraSure (Nasdaq: OSUR) at Buy with a price target of $8 following news of a terminated HCV co-promotion ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
